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ROBERTSON and Schwartz (1953) showed that " carrageenin ", (a sulphated
polygalactose made from the sea weed, Irish moss, Chondru83 crispus,) when
injected subcutaneously into guinea-pigs would induce the proliferation of fibro-
blasts and the formation of a connective tissue granuloma. This technique was
used to study the biochemistry of collagen formation by Jackson (1956a 1956b,
1957), Slack (1956, 1957, 1958), Robertson and Hinds (1956), Robertson, Hiwett
and Herman (1959). The histology of the lesions produced has been described
by Williams (1957) and Benitz and Hall (1959).
Walpole, Roberts, Rose, Hendry and Homer (1954) showed that several simple
monofunctional, N-acylethyleneimines would produce tumours in rats and mice
when given by repeated subcutaneous injections. In no case, however, was a
tumour produced by a single dose of the carcinogen. It therefore appeared of
interest to see if a single dose of an ethyleneimine would induce a tumour if it
was injected into the mass ofyoung fibroblasts produced by carrageenin. Young
female rats were therefore given an injection of carrageenin into the left flank
and injections ofacylethyleneimine into both right and left flanks. The injection
ofcarcinogen into the left flank was placed in the centre ofthe carrageenin induced
granuloma and was timed to coincide with its height. A large number of rats
produced sarcomas-all onthe left side-but controlrats, injected with carrageenin
only, also produced sarcomas. Although no synergy between carcinogen and
carrageenin could be demonstrated, the changes produced by the carrageenin
in the mammary glands of the rats, and the changes leading to the formation of
the tumours are of interest and are described in this report.
METHODS
Female Wistar rats 60 days old and between 100 to 130 g. in weight were
injected into the left flank with 5 ml. of 1 per cent w/v carrageenin in 0 9 per cent
salt solution. Three days later they were injected into the right flank with 1.5
mg. of caproylethyleneimine in 0 15 ml. arachis oil, and on the 7th day a similar
quantity of caproylethyleneimine was injected into the middle of the carrageenin
induced mass in the left flank. Some preliminary experiments had confirmed
that 7 days after the injection of carragenin there were numerous young fibro-
blasts present in the mass of new fibrous tissue which had been induced. The
two doses ofethyleneimine were given on separate days to avoid loss ofrats from
the toxicity of this reactive compound. In all four batches of rats were used:
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Preliminary Experiment:
Group A 47 injected carrageenin left side and caproylethyleneimine on
both sides.
Maii Experiment:
Group B 28 injected carrageenin left side and caproylethyleneimine on
both sides.
Group C 28 injected carrageenin left side and acetylethyleneimine on
both sides.
Group D 43 injected carrageenin left side and saline on both sides.
When the rats developed tumours or were ill from other causes they were
killed andthe mammary tissuefrom both sides was taken for section. Any tumour
or other lesion was also examined by routine histological techniques.
Carrageenin (lot 8-9-55) was kindly provided by Mr. L. Stoloff of the Sea
Plant Chemical Corporation. 5 g. were dissolved in 500 ml. of 0 9 per cent NaCI
and the solution was sterilised by heating in a water bath for 30 minutes.
The caproylethyleneimine and the acetylethyleneimine were kindly provided
by Dr. F. L. Rose of the Imperial Chemical Industries. It was already made up
in solution 10 mg./ml. %v/v in arachis oil.
RESULTS
In the preliminary experiment (group A) 16 rats were killed 307 days after the
injection of carrageenin. At autopsy it was noted that the mammary tissue on
the left side differed markedly in appearance from that on the right side. The
right side showed a little, rather thin mammary tissue embedded in normal
subcutaneous fat, typical of a rather senile, resting mammary gland. On the
left side the mammarv tissue was much thicker, there was dilatation of the small
vessels, the fat was yellow or brown and was sometimes creamy in consistency
and the tissue was adherent to the skin. Because of these changes the remaining
animals were allowed to survive until they had produced tumours or were ill or
died. No rats produced sarcomas on the right side, but 9 out of 18 rats surviving
inore than 400 days produced sarcomas on the left side. The main experiment
was therefore set up consisting ofgroups B, C and D (Table I). In this experiment
all the sarcomas arose in the left flank, but it showed the unexpected result that
carrageenin alone would induce sarcomata. We were not able to prove by the
detailed statistical analysis, given below, that a single dose of an acylethylenei-
mine given into the carrageenin-induced granuloma had a significant synergistic
effect in producing more sarcomas or shortening the induction period.
Statistical analysis
Table I shows the tumour incidence and the mean induction time of tumours
of th. 4 groups of animals surviving more than 400 days. Since experiment A
was terminated after 650 days, the mean induction times of tumours for groups
B, C and D up to 650 days were also computed to allow comparison with experi-
ment A. The table shows that there are no statistically significant differences
between the three groups B, C and D after 650 days. The principal difference
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in mean induction times at 650 days is between group A and the other three
groups. The difference between groups A and B is not significant at the 5 per
cent level. The difference between groups A and C, and A and D exceed twice
their standard errors, but it is not possible to assess the precise significance of
their difference owing to uncertainty as to the degrees of freedom that should be
attached to the standard errors. Sukhatme's d test (Fisher and Yates, 1953,
Table V. 1) indicates, however, that the differences are near the 5 per cent level.
Furtber the larger standard deviation of group A (which is approximately given
by /9 x 20-8 = 62.4) compared with the other groups suggests that the form of
the distribution of induction times for group A may be different from that of
groups B, C and D.
After 825 days, there is no statistically significant difference between the mean
induction times for groups B, C and D. If the results from groups A and B are
pooled there is no statisticant difference between the mean induction time for
this group and the remaining two groups C and D.
Table II shows, assuming no deaths from other causes, the number of rats per
thousand that would be expected to have developed tumours after both 650 and
825 days. After 650 days there is no statistically significant difference between
groups B, C and D, but there is between these groups and group A, the latter
developing more tumours per thousand. After 825 days there is again no
statistically significant difference between groups B, C and D.
The figures were computed according to Irwin (1949)
Macroscopic changes induced by carrageenin
A mass was palpable in the region of the injection site for about two weeks.
Loss of hair was noticed over the injection site commencing about three weeks
after the injection and persisting in many cases for many months. When tumours
began the palpable mass usually increased very rapidly in size. In most cases
it was necessary to kill the animal within three weeks offirst detecting the tumour,
but sometimes a small mass was felt for some weeks andthen suddenlyincreased
rapidly in size. The changes in the mammary tissue at autopsy included:
a visible increase in the amount of mammary tissue on the left side, a fluid or
creamy consistency of the fat, numerous small vessels in the injection area and
adherence of the mass to the skin.
Histological appearances of the changes induced by carrageenin
The essential changes induced by carrigeenin can be described under 6 headings.
1. The early changes.-These consist ofan accumulation ofpolymorphonuclear
leukocytes, macrophages with phagocytosed polysaccharide and fibroblasts.
Fig. 1 shows the appearance one week after the injection and shows many macro-
phages and numerous young fibroblasts. Later mature collagen fibres are in
greater evidence. The early changes have been described in detail by Williams
(1957) and Benitz and Hall (1959) and need not be further elaborated here.
2. Degeneration of mammary gland epithelium was seen in progress even
more than two years after the carrageenin injection. Fig. 2 shows the typical
appearance of the unaffected mammary tissue on the right side. Note a small
cluster of gland alveoli separated by much adipose tissue from its nearest neigh-
bour. Note also the thin walled normal capillaries. Fig. 3 shows that the changes
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induced by carrageenin are still progressing 813 days after injection. Note in
the centre of the field mammary epithelial cells in process of degeneration. In
other parts of the field the empty spaces represent gland alveoli which have
degenerated. There is a great increase of the intra-lobular fibrous tissue.
3. Invasion of degenerated gland alveoli by fibroblasts.-Fig. 4 shows a good
example of this in the lower part of the field; note how the space left by a mam-
mary gland alveolus which has degenerated has now been filled with a group of
fibroblasts. A somewhat earlier stage of this process is seen near the middle of
the right margin of this picture.
4. Thickening of the walls of the capillaries and arterioles.-This change which
can be seen in Fig. 3 and 4 is illustrated more clearly in Fig. 5, 6 and 7. Fig.
5 is stained with methyl violet and shows the thick layer of hyaline material
surrounding the endothelial lining of the capillary. There are many mast cells
present immediately outside this hyaline material. With methyl violet the hya-
line material is faintly metachromatic and the mast cells stain deep blue. Fig.
6 is from the same block and is stained with P.A.S. At the bottom of the picture
the thickened capillaries and the mast cells are very clear,. In the top right hand
corner, there are capillaries with walls as much as 4 times as thick as the diameter
of the capillary lumen. Fig. 7, stained with haematoxylin and eosin, shows a
small arteriole with a greatly thickened wall running in a tortuous spiral diagonally
across the field. Other thickened vessels can be easily identified in other parts
of this picture.
5. Involvement of small nerves in the fibrous tissue.-The fibrous tissue re-
placement of the mammary tissue appears to enmesh many small nerves. Fig.
8 shows a typical field. Fig. 9 shows four ofthe changes induced by carrageenin:
-the cells lining the mammary gland alveoli have become pale staining, with
vacuolated cytoplasm and small pyknotic nuclei; there is definite replacement
of gland cells by fibroblasts in the central alveolus; the capillary walls are thick-
ened and a small nerve has been caught in the area of fibrosis.
6. Sarcomatous changes.-Zones of precancerous proliferation and early
sarcomatous changes were seen in some of the sections. Fig. 10 is from a zone
I to 2 mm. across which contains many large cells with heavy staining and
abnormal nuclear formations. Fig. 11 shows part ofan early fibroblastic sarcoma.
Most ofthe large tumours were ofthis type but some were fibro-sarcomata contain-
ing collagen fibres stainable by Van Gieson and some were more anaplastic in type.
One typical myxosarcoma was seen.
One rat with a large fibroblastic type sarcoma had bilateral deposits at the
lower poles of both kidneys, see Fig. 12 which shows the tumour cells infiltrating
between the kidney tubules. A lymphosarcoma of the thymus was also noted in
another rat.
DISCUSSION
The original purpose of the experiment was to show whether a single dose of
an acylethyleneimine, a simple but short acting carcinogen, would produce a
tumour if placed in contact with young, actively growing fibroblasts. The whole
basis of the experiment was invalidated by the quite unexpected finding that
carrageenin by itself would produce sarcomata. Careful statistical analysis of
the results did not show a significant synergistic activity of the single dose of
ethyleneimine and the carrageenin.
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The long-lasting changes produced by the carrageenin were also quite un-
expected. Williams (1957) and Benitz and Hall (1959) described the histological
changes produced by carrageenin in the first 28 days following injection. The
author has been unable to find any description in the literature of the late effects
ofinjected carrageenin. The degenerative changes in mammary gland epithelium
and replacement by fibroblasts are what might have been anticipated but the
curious changes in the small vessels were a surprise. The small vessels appear
like pipes with thick walls, the hyaline material stains slightly pink with methyl
violet, red with periodic-Schiff, eosinophil with haematoxylin and eosin and blue
with the picro Mallory stains. Frequently there are many mast cells surrounding
these vessels. It is possible that the chronic changes in the mammary gland are
due to the interference with its blood supply, but macroscopically the car-
rageenin-injected tissue appears to be much more vascular than the control gland.
The loss of hair over the injection site is also something of a mystery. It
might be due to irritation and scratching by the animal-irritation due to
alterations of blood supply or the inclusion of nerve fibres in the mass of fibrous
tissue. On the the other hand the hair loss might be due to the interference with
the subepidermal layer of elastic tissue and hair follicles. Williams (1957)
notes that intradermal injection of carrageenin in the guinea-pig produced after
5 days a degeneration of the collagenous fibres in the dermis, and despite partial
remodelling in the later stages the dermis suffered a substantial loss of its col-
lagenous tissue. My clinical impression is that some of the changes in the skin
EXPLANATION OF PLATES
FIG. 1.-Subcutaneous tissue of a rat 7 days after injection of carrageenin only; note the
numerous macrophages and fibroblasts. H. &E. x 570.
FIG. 2.-Control mammary tissue (on right side) 722 days after start of experiment. Note
thin walled capillary and much interlobular adipose tissue. Picro Mallory. x 475.
FIG. 3.-Degeneration of mammary gland epithelium with increase of intralobular fibrosis and
hyaline thickening ofcapillary walls seen 454 days after injection of carrageenin + caproyl-
ethyleneimine. Picro Mallory. x 360.
FIG. 4. Degenerated mammary gland epithelium being replaced by fibroblasts, see gland
alveolus at bottom centre, also hyaline thickening ofcapillary walls, 545 days after injection
of carrageenin + acetylethyleneimine. Picro Mallory. x 360.
FIG. 5.-Hyaline thickening of capillary walls which are surrounded by mast cells, same rat
as Fig. 3, 454 days after injection of carrageenin + caproylethyleneimine. Methyl violet.
x360.
FIG. 6.-From the same rat as Fig. 3 and 5, stained with PA.S. x 360.
FIG. 7.-Tortuous arterioles and capillaries with hyaline thickening of their walls, 803 days
after injection of carrageenin, only. H. & E. x 360.
FIG. 8.-A number of fine nerves caught in the fibrous tissue replacing the mammary tissue
813 days after injection of carrageenin only. Picro Mallory. x 360.
FIG. 9.-Typical carrageenin changes-pale vaculated mammary gland epithelium with
pyknotic nuclei with replacement by fibroblasts, upper centre; there is a small nerve
caught in the process and some hyaline thickening of capillary walls 562 days after injec-
tion of carrageenin + acetylethyleneimine. Picro Mallory. x 360.
FIG. 10.-Section from a small zone 1-2 mm. in diameter in which sarcomatous transforma-
tion has taken place, 545 days after injection of carrageenin + acetylethyleneimine.
H. & E. x360.
FIG. 11.-Typical fibroblastic type ofsarcoma 618 days after carrageenin injection + caproyl-
ethyleneimine. The tumour 40 x 15 x 15 mm. in size appeared 28 days previously.
H. & E. x570.
FIG. 12.-Tumour invading right kidney. There is a pleomorphic-cell sarcoma in left flank
722 days after injection of carrageenin + acetylethyleneimine. H. & E. x 360.
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in the rats were the result of scratching. Not infrequently scratch marks could
be seen on the area showing loss of hair, and in a few rats shallow ulcers or scabs
were present from time to time. At autopsy the skin appeared to be thin and
definitely adherent to the mammary tissue and the vessels immediately beneath
the epidermis were engorged. The loss of hair persisted for many months.
The precise aetiology of the tumours is equally mysterious. There are
several possibilities and these are not mutually exclusive:
1. Often repeated trauma due to irritation and scratching.
2. Anoxia due to the changes in the vessels.
3. Induction of a tumour in relation to material which cannot be removed
from the tissues e.g. tumours induced by plastic films (Oppenheimer, Stout,
Oppenheimer and Willhite, 1957).
4. A chronic or repeated stimulus to the production of fibroblasts due to the
continued presence of carrageenin acting as a fibroblastic ground substance, or
due to the damage which it has caused.
5. The fibrous tissue response to an abnormal ground substance may not be
a normal response. For instance Vasiliev (1959) noted that the connective tissue
reaction to a pellet containing dimethylbenzanthracene or methylcholanthrene
was abnormal-" a distorted fibrogenesis " in which after 3 or 4 monthsmultiple
sarcomatous focci appear.
SUTMMARY
1. Young female rats were injected into the right flank with a single dose of
an acylethyleneimine and into the left flank with a sulphated polygalactose,
carrageenin, followed 7 days later by an injection of the acylethyleneimine into
the carrageenin induced mass of fibroblasts.
2. Control rats were injected with carrageenin into the left flank and with
saline into both flanks.
3. No rats produced sarcomas on the right side, but 11 out of 39 control rats
developed a sarcoma on the side injected with carrageenin.
4. 5 out of 23 rats injected with carageenin + caproylethyleneimine and 9 out
of 25 rats injected with carageenin + acetylethyleneimine developed sarcomas on
the left side, but there was no statistical evidence that the acylethyleneimine
had increased the incidence oftumours or shortened the induction period, but in a
preliminary experiment using caproylethyleneimine more sarcomata were pro-
duced at an earlier date.
5. Carrageenin induced a degeneration of mammary gland epithelium with
fibrous tissue replacement and a hyaline thickening of capillary walls. Numerous
small nerves were caught in the fibrosis and there was prolonged loss of hair over
the injection site.
I wish to thank Dr. F. L. Rose, F.R.S., of Imperial Chemical Industries Ltd.,
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of the Seaplant Chemical Corporation for the carrageenin. I am greatly in-
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